Futura Medical (FUM) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Apr 2023 07:00 AM
RNS
TR-1: Notification of major holdings
24 Apr 2023 07:00 AM
RNS
TR-1: Notification of major holdings
18 Apr 2023 07:00 AM
RNS
MED3000, Eroxon® UK Launch
06 Apr 2023 11:03 AM
RNS
Directors' / PDMR Dealing and Grant of Options
05 Apr 2023 07:00 AM
RNS
Full Year Results ended 31 December 2022
29 Mar 2023 07:00 AM
RNS
Update on MED3000 regulatory approval in the US
27 Mar 2023 05:24 PM
RNS
Notice of Preliminary Results 2022
14 Mar 2023 08:33 AM
RNS
MED3000 commercial and US regulatory update
15 Feb 2023 07:00 AM
RNS
MED3000 FM71 Presentation at ESSM Congress 2023
01 Feb 2023 01:26 PM
RNS
Block Listing Applications to AIM
26 Jan 2023 07:00 AM
RNS
Pre-launch of MED3000 ahead of H1 2023 launch
12 Jan 2023 11:09 AM
RNS
Futura Remuneration, Options & Total Voting Rights
15 Dec 2022 03:01 PM
RNS
TR-1: Notification of major holdings
13 Dec 2022 01:08 PM
EQS
Futura Medical 'on track' for launch in H1 2023
13 Dec 2022 07:00 AM
RNS
Futura Medical announce milestone year for MED3000
30 Nov 2022 07:00 AM
RNS
Futura Block Listing Six Monthly Return
30 Nov 2022 07:00 AM
RNS
Total Voting Rights
21 Oct 2022 04:40 PM
RNS
Second Price Monitoring Extn
21 Oct 2022 04:35 PM
RNS
Price Monitoring Extension
12 Oct 2022 12:25 PM
RNS
TR-1: Notification of major holdings
04 Oct 2022 05:31 PM
RNS
Total Voting Rights
03 Oct 2022 07:00 AM
RNS
Application to the US FDA for MED3000
16 Sep 2022 09:57 AM
RNS
PDMR Dealing and Total Voting Rights
13 Sep 2022 07:00 AM
RNS
Futura Medical Interim Results 2022
01 Sep 2022 07:00 AM
RNS
Notice of Interim Results
31 Aug 2022 07:00 AM
RNS
Highly positive FM71 Phase 3 Study Results
12 Jul 2022 04:41 PM
RNS
Second Price Monitoring Extn
12 Jul 2022 04:35 PM
RNS
Price Monitoring Extension
28 Jun 2022 03:58 PM
RNS
Futura Medical AGM Results
28 Jun 2022 07:00 AM
RNS
Futura Medical AGM Statement
07 Jun 2022 01:33 PM
RNS
TR-1: Notification of major holdings
01 Jun 2022 07:00 AM
RNS
Notice of AGM and Availability of Annual Report
31 May 2022 07:00 AM
RNS
Block Listing Six Monthly Return
24 May 2022 11:40 AM
RNS
TR-1: Notification of major holdings
23 May 2022 10:35 AM
RNS
Agreement with Cooper Consumer Health - Correction
23 May 2022 07:00 AM
RNS
MED3000 Collaboration in EEA, UK & Switzerland
17 May 2022 03:56 PM
RNS
TR-1: Notification of major holdings
16 May 2022 02:51 PM
RNS
TR-1: Notification of major holdings
13 May 2022 12:12 PM
RNS
TR-1: Notification of major holdings
06 May 2022 04:41 PM
RNS
Second Price Monitoring Extn
06 May 2022 04:35 PM
RNS
Price Monitoring Extension
26 Apr 2022 07:00 AM
RNS
Full Year Results 2021
14 Apr 2022 03:54 PM
RNS
Futura Medical Notice of Preliminary Results 2021
11 Apr 2022 04:28 PM
RNS
TR-1: Notification of major holdings
01 Apr 2022 04:58 PM
RNS
TR-1: Notification of major holdings
23 Mar 2022 07:00 AM
RNS
Futura Announces Collaboration with Menarini
02 Feb 2022 05:30 PM
RNS
TR-1:Notification of major holdings
13 Jan 2022 10:32 AM
RNS
Remuneration of Non-Executive Directors and TVR
20 Dec 2021 07:00 AM
RNS
US regulatory and commercial update for MED3000
02 Dec 2021 12:02 PM
RNS
TR-1: Notification of major holdings

Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

FUM share price listed on AIM in 2003.

UK 100

Latest directors dealings